---
title: "Canton Strategic sells Gravitas Life Sciences to Gravitas Collective Corp"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293613353.md"
description: "Canton Strategic Holdings sold its biotech R&D unit, Gravitas Life Sciences, to Gravitas Collective Corp. The deal closed on July 17, 2026. This divestment sharpens Canton's focus on the Canton Network strategy to digitize traditional financial markets, following progress in its operating business, including a locking service launched in June 2026."
datetime: "2026-07-23T12:06:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293613353.md)
  - [en](https://longbridge.com/en/news/293613353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293613353.md)
generator: "portal-rs"
---

# Canton Strategic sells Gravitas Life Sciences to Gravitas Collective Corp

-   Canton Strategic Holdings sold its biotech R&D unit, Gravitas Life Sciences, to Gravitas Collective. \* Deal closed July 17, 2026. \* Divestment sharpens focus on the Canton Network strategy to digitize traditional financial markets. \* Shift follows progress in the operating business, including a locking service launched in June 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canton Strategic Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY10865) on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CNTN.US](https://longbridge.com/en/quote/CNTN.US.md)

## Related News & Research

- [Canton Strategic Holdings, Inc. Announces Authorization of Share Repurchase Program | CNTN Stock News](https://longbridge.com/en/news/289921324.md)
- [Canton: Zenith enables native EVM execution - 01 Aug 2026](https://longbridge.com/en/news/294585111.md)
- [Cambi unit Grønn Vekst wins Eidsvoll biosolids management contract worth NOK 15-50 million](https://longbridge.com/en/news/296604282.md)
- [Concentra names Jill Rosenthal chief medical officer, effective Jan. 1, 2027](https://longbridge.com/en/news/296232672.md)
- [Klappir publishes investor presentation for Class B share offering at EUR 3.43 per share](https://longbridge.com/en/news/296407110.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**